Influence of fasting on the effects of dimethylamiloride and oxfenicine on ischaemic-reperfused rat heartsMARINA PRENDES, M. G; GARCIA, J. V; TESTONI, G et al.Archives of physiology and biochemistry. 2006, Vol 112, Num 1, pp 31-36, issn 1381-3455, 6 p.Article

Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicineSTEPHENS, T. W; HIGGINS, A. J; COOK, G. A et al.Biochemical journal (London. 1906). 1985, Vol 227, Num 2, pp 651-659, issn 0006-2936Article

Investigation of the solubility relationships of polar, semi-polar and non-polar drugs in mixed co-solvent systemsGOULD, P. L; GOODMAN, M; HANSON, P. A et al.International journal of pharmaceutics. 1984, Vol 19, Num 2, pp 149-159, issn 0378-5173Article

Oxfenicine-induced accumulation of lipid in the rat myocardiumJODALEN, H; YTREHUS, K; MOEN, P et al.Journal of molecular and cellular cardiology. 1988, Vol 20, Num 3, pp 277-282, issn 0022-2828Article

THE EFFECT OF OXEFENICINE ON CARDIAC CARBOHYDRATE METABOLISM IN INTACT DOGSDRAKE HOLLAND AJ; PASSINGHAM JE.1983; BASIC RESEARCH IN CARDIOLOGY; ISSN 0300-8428; DEU; DA. 1983; VOL. 78; NO 1; PP. 19-27; ABS. GER; BIBL. 24 REF.Article

MECHANISM OF ACTION OF OXFENICINE ON MUSCLE METABOLISMHIGGINS AJ; MORVILLE M; BURGES RA et al.1981; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1981; VOL. 100; NO 1; PP. 291-296; BIBL. 11 REF.Article

PROTECTION OF THE ISCHAEMIC DOG HEART BY OXFENICINEBURGES RA; GARDINER DG; HIGGINS AJ et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 29; NO 18; PP. 1847-1853; BIBL. 10 REF.Article

OXFENICINE DIVERTS RAT MUSCLE METABOLISM FROM FATTY ACID TO CARBOHYDRATE OXIDATION AND PROTECTS THE ISCHAEMIC RAT HEARTHIGGINS AJ; MORVILLE M; BURGES RA et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 11; PP. 963-970; BIBL. 22 REF.Article

Bochemical mechanisms of oxfenicine cardiotoxicityBACHMANN, E; WEBER, E.Pharmacology. 1988, Vol 36, Num 4, pp 238-248, issn 0031-7012Article

Effects of acetyl-L-carnitine and oxfenicine on aorta stiffness in diabetic ratsCHANG, Kuo-Chu; TSENGT, Chuen-Den; LU, Shao-Chun et al.European journal of clinical investigation. 2010, Vol 40, Num 11, pp 1002-1010, issn 0014-2972, 9 p.Article

DETERMINATION OF THE ENANTIOMERIC PURITY OF OXFENICINE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYCOLEMAN MW.1983; CHROMATOGRAPHIA; ISSN 0009-5893; DEU; DA. 1983; VOL. 17; NO 1; PP. 23-26; BIBL. 12 REF.Article

Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia- Reperfusion Injury (I/R) in a Model of Diet-Induced ObesityMAARMAN, Gerald; MARAIS, Erna; LOCHNER, Amanda et al.Cardiovascular drugs and therapy. 2012, Vol 26, Num 3, pp 205-216, issn 0920-3206, 12 p.Article

Partial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemiaCHANDLER, Margaret P; CHAVEZ, Pedro N; MCELFRESH, Tracy A et al.Cardiovascular research. 2003, Vol 59, Num 1, pp 143-151, issn 0008-6363, 9 p.Article

Effects of fasting, hypoxia, methylpalmoxirate and oxfenicine on the tissue-levels of long-chain acyl CoA and acylcarnitine in the rat atriaVARELA, A; CARREGAL, M; TESTONI, G et al.Archives of physiology and biochemistry. 1997, Vol 105, Num 6, pp 572-576, issn 1381-3455Article

Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfenicine in cardiac muscleBIELEFELD, D. R; VARY, T. C; NEELY, J. R et al.Journal of molecular and cellular cardiology. 1985, Vol 17, Num 6, pp 619-625, issn 0022-2828Article

Effects of oxfenicine on the atria from fed and fasted ratsVARELA, A; CARREGAL, M; ESPOSITO, S et al.Archives internationales de physiologie, de biochimie et de biophysique. 1994, Vol 102, Num 2, pp 125-128, issn 0778-3124Conference Paper

Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardiumMOLAPARAST-SALESS, F; LIEDTKE, A. J; NELLIS, S. H et al.Journal of molecular and cellular cardiology. 1987, Vol 19, Num 5, pp 509-520, issn 0022-2828Article

Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine]KORB, H; HOEF, A; HUNNEMAN, D. H et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 327, Num 1, pp 70-74, issn 0028-1298Article

Effects of Metabolic Approach in Diabetic Patients with Coronary Artery Disease : The Metabolic Treatment of Coronary Artery Disease and Heart FailureFRAGASSO, Gabriele; SALERNO, Anna; SPOLADORE, Roberto et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 8, pp 857-862, issn 1381-6128, 6 p.Article

Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemiaCHAVEZ, Pedro N; STANLEY, William C; MCELFRESH, Tracy A et al.American journal of physiology. Heart and circulatory physiology. 2003, Vol 53, Num 5, pp H1521-H1527, issn 0363-6135Article

Effect of Perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heartKENNEDY, Jennifer A; KIOSOGLOUS, Anthony J; MURPHY, Geraldine A et al.Journal of cardiovascular pharmacology. 2000, Vol 36, Num 6, pp 794-801, issn 0160-2446Article

Limitation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardiumVIK-MO, H; MJØS, O. D; NEELY, J. R et al.The American heart journal. 1986, Vol 111, Num 6, pp 1048-1054, issn 0002-8703Article

Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic heartsLIEDTKE, A. J; NELLIS, S. H; MJØS, O. D et al.American journal of physiology. Heart and circulatory physiology. 1984, Vol 16, Num 3, pp H387-H394, issn 0363-6135Article